← Human Trials & Peer-Reviewed Studies
The effect of short-term growth hormone treatment on growth and energy expenditure in burned children.
Plain-language guide to PMID 11451596 (2001): controlled clinical trial of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 38 children.
Key Facts
- PMID
- 11451596
- Journal
- Burns : journal of the International Society for Burn Injuries
- Year
- 2001
- Study type
- Controlled Clinical Trial
- Authors
- Aili Low JF et al. (6 authors)
- DOI
- 10.1016/s0305-4179(00)00164-9
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over), published as a controlled clinical trial.
To determine the effect of rhGH on energy requirements, resting energy expenditures (REE) were measured by indirect calorimetry and compared to values calculated from the Harris-Benedict equation.
Why It Was Studied
Delays in growth are commonly observed in children who have sustained a severe cutaneous burn.
If this is also the case in severely burned children, the low GH levels may contribute to their chronic growth delay.
Who Took Part
The abstract describes 38 children taking part.
By PubMed's age tags, the people studied were young children, children and teenagers, both men and women.
What Was Measured
If this is also the case in severely burned children, the low GH levels may contribute to their chronic growth delay.
Topics PubMed links to this paper include Body Height, Burns, Child Development, Energy Metabolism, Human Growth Hormone, Injury Severity Score and Probability.
What This Means in Plain Language
This is a controlled clinical trial of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 38 children.
With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.
The publication is from 2001 (Burns : journal of the International Society for Burn Injuries), a journal based in Netherlands.
More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.
Our Notes on the Compound
Exogenous HGH, sermorelin & older GHRPs (why they're passed over): Constant levels suppress the body's own GHRH, raise somatostatin and dull pituitary response.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.